NFKB1 and neoplasm: The impaired ISGs signaling disrupt the production of chemokines and antigen-presenting molecules such as MHC, leading to inadequate antiviral responses and the initiation of cancers.147 E6-mediated STAT3 upregulation promotes tumor growth by suppressing immune responses that are partially dependent on the NF-κB pathway.